Stock of this pharma company has zoomed nearly 90% in last four months

In the past three months, Unichem Labs has received abbreviated new drug application (ANDA) approvals for four drugs from the United States Food and Drug Administration (USFDA)

Unichem Laboratories. Photo:

Unichem Laboratories. Photo:

SI Reporter Mumbai
Shares of Unichem Laboratories continued their upward march, rallying 5 per cent to hit a new high of Rs 452.95 on the BSE in Thursday’s intra-day trade.

In the past four trading days, the stock has surged 17 per cent. In the past four months, it has zoomed nearly 90 per cent. Further, in the past one year, the stock of the drug maker has seen its market price more-than-double (up 102 per cent), as compared to a 2 per cent rise in the S&P BSE Sensex.

First Published: Nov 03 2022 | 12:11 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to